VASCULITIS FOUNDATION

EIN: 431492959 501(c)(3)

KANSAS CITY, MO

Total Revenue
$2,508,810
Total Expenses
$2,383,106
Total Assets
$6,087,497
Net Assets
$5,941,379
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
1988
Legal Domicile
MO
Principal Officer
KEVIN BYRAM MD
Phone
8164368211
Tax Period
2024-07-01 to 2025-06-30

VASCULITIS FOUNDATION, founded in 1988, is a community nonprofit that reported $2.5M in total revenue in fiscal year 2024. Revenue decreased 15% compared to the prior year. Expenses of $2.4M left a modest 5% surplus.

Mission

BUILDING UPON THE COLLECTIVE STRENGTH OF THE VASCULITIS COMMUNITY, THE VASCULITIS FOUNDATION SUPPORTS, INSPIRES AND EMPOWERS INDIVIDUALS WITH VASCULITIS AND THEIR FAMILIES THROUGH A WIDE RANGE OF EDUCATION, RESEARCH, CLINICAL, AND AWARENESS INITIATIVES. OUR VISION IS TO BE THE LEADING ORGANIZATION IN THE WORLD DEDICATED TO DIGANOSING, TREATING, AND CURING ALL FORMS OF VASCULITIS.

Program Service Accomplishments

Program 1
Expenses: $900,946 Revenue: $64,436

BUILDING UPON THE COLLECTIVE STRENGTH OF THE VASCULITIS COMMUNITY, THE VASCULITIS FOUNDATION (VF) SUPPORTS, INSPIRES, AND EMPOWERS INDIVIDUALS WITH VASCULITIS AND THEIR FAMILIES THROUGH A WIDE RANGE...

Read more

BUILDING UPON THE COLLECTIVE STRENGTH OF THE VASCULITIS COMMUNITY, THE VASCULITIS FOUNDATION (VF) SUPPORTS, INSPIRES, AND EMPOWERS INDIVIDUALS WITH VASCULITIS AND THEIR FAMILIES THROUGH A WIDE RANGE OF EDUCATION, FELLOWSHIP, RESEARCH, CLINICAL, AND AWARENESS INITIATIVES. OUR VISION IS TO BE THE LEADING ORGANIZATION IN THE WORLD DEDICATED TO DIAGNOSING, TREATING, AND CURING ALL FORMS OF VASCULITIS. THE VF PROVIDES SUPPORT THROUGH ITS EXTENSIVE WEBSITE, MONTLHY E-NEWSLETTERS, ELECTRONIC AND PRINTED EDUCATIONAL MATERIALS, PHONE AND EMAIL OUTREACH. WEBSITE VISITORS: 35,000 ANNUALLY; YOUTUBE SUBSCRIBERS: 10,000+ ANNUALLY; MONTHLY E-NEWSLETTER DISTRIBUTION: MORE THAN 14,000 SUBSCRIBERS; AND 3,500 PHONE AND EMAIL REQUESTS FOR ASSISTANCE THIS YEAR. THE VF OFFERS 9 VIRTUAL SUPPORT GROUP MEETINGS MONTHLY FOR PATIENTS OF ALL AGES AND THEIR PARENTS AND CAREGIVERS, ATTRACTING AS MANY AS 275 PARTICIPANTS A MONTH. THE VF OFFERS WIDE-RANGING LIVE AND ON-DEMAND WEBINARS WHICH ADDRESS DISEASE SPOTLIGHTS, MENTAL HEALTH/WELLNESS, RESEARCH, THERAPIES AND TREATMENTS. THE VF HAD 100+ WEBINARS WITH 7,020 HOURS WATCHED, AND 150,000+ VIEWS ON VF'S YOUTUBE EDUCATION CHANNEL. THE VF TEAM HAS BEEN ON THE ROAD THIS YEAR EDUCATING OUR PATIENT COMMUNITY AT REGIONAL CONFERENCES IN AUSTIN, CLEVELAND, NASHVILLE, SANTA MONICA, SCOTTSDALE, SEATTLE, AND WASHINGTON, DC. THE VF TEAM ALSO RAISED AWARENESS IN THE MEDICAL COMMUNITY BY EXHIBITING AT INTERNATIONAL MEDICAL CONFERENCES INCLUDING THE AMERICAN COLLEGE OF RHEUMATOLOGY, AMERICAN SOCIETY OF NEPHROLOGY, AMERICAN THORACIC SOCIETY, CARRA, AND RH APP.

Program 2
Expenses: $621,816

VASCULITIS - BUILDING OUTCOMES, LEADING DISCOVERIES (V-BOLD) PROGRAM COMBINES RESEARCH, FELLOWSHIPS, VASCULITIS CENTERS, AND THE VPPRN WITH THE GOAL TO IMPROVE THE QUALITY OF LIFE FOR PATIENTS WITH...

Read more

VASCULITIS - BUILDING OUTCOMES, LEADING DISCOVERIES (V-BOLD) PROGRAM COMBINES RESEARCH, FELLOWSHIPS, VASCULITIS CENTERS, AND THE VPPRN WITH THE GOAL TO IMPROVE THE QUALITY OF LIFE FOR PATIENTS WITH VASCULITIS, AND ULTIMATELY FIND THE CAUSE(S) AND CURE FOR VASCULITIS. RESEARCH: THE VF YOUNG INVESTIGATOR AWARD PROVIDES ONE OR TWO-YEAR GRANTS OF UP TO 50,000 TO SUPPORT RESEARCHERS WITHIN FIVE YEARS OF THE COMPLETION OF THEIR FELLOWSHIPS. THE FUNDING SUPPORTS PILOT STUDIES IN RESEARCHING DIAGNOSIS, ETIOLOGY/PATHOGENESIS, EPIDEMIOLOGY, AND TREATMENT/MANAGEMENT. FELLOWSHIPS: THE VF PARTNERS WITH ACADEMIC INSTITUTIONS AND THE VASCULITIS CLINICAL RESEARCH CONSORTIUM (VCRC) TO PROVIDE FELLOWSHIPS FOR PHYSICIAN- INVESTIGATORS WHO HAVE A STRONG INTEREST IN VASCULITIS. THIS MENTORED TRAINING PROGRAM EMPHASIZES CLINICAL, PATIENT-ORIENTED INVESTIGATION. VASCULITIS CENTERS ARE ESSENTIAL IN THE PATIENT JOURNEY - FROM DIAGNOSIS TO TREATMENT TO REMISSION, WITH THE POTENTIAL FOR CURES. VASCULITIS CENTERS PROVIDE COMPREHENSIVE, HIGH-QUALITY, AND COMPASSIONATE CARE TO PATIENTS WITH VASCULITIS. IN ADDITION, THEY HAVE THE CAPACITY TO ADVANCE OUR UNDERSTANDING OF VASCULITIS THROUGH RESEARCH. WITH EXPERTS IN THE MANAGEMENT AND STUDY OF THE DISEASE, VASCULITIS CENTERS ARE AT THE FOREFRONT OF SPECIALTY CARE AND CLINICAL RESEARCH, WHILE TREATING ALL TYPES OF VASCULITIS. IN 2024-25, VF FUNDED 10 GRANTS TOTALLING 246,907. VASCULITIS PATIENT-POWERED RESEARCH NETWORK (VPPRN) IS THE INTERNATIONAL RESEARCH NETWORK OF PATIENTS, SCIENTISTS, CLINICIANS, ADVOCATES AND FAMILY MEMBERS WHO WORK TO IMPROVE THE HEALTH CARE AND QUALITY OF LIFE FOR PEOPLE WITH VASCULITIS THROUGH HIGH-LEVEL CLINICAL RESEARCH.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $2,299,448
Program Service Revenue $64,436
Investment Income $144,926
Other Revenue $0
TOTAL REVENUE $2,508,810

Expense Breakdown

Grants Paid $246,907
Salaries & Benefits $911,909
Fundraising Expenses $248,744
Program Expenses $1,522,762
Other Expenses $1,224,290
TOTAL EXPENSES $2,383,106

Year-over-Year Comparison

2024 2023 Change
Revenue $2,508,810 $2,956,706 -0.2%
Expenses $2,383,106 $2,090,325 +0.1%
Net Income $125,704 $866,381 -0.9%
Key Indicators
Grants to Organizations Grants to Individuals Lobbying Political Activity Foreign Activities Donor Advised Fund Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
12
Independent Members
12
Employees
11
Volunteers
150

Governance Policies

Conflict of Interest Policy
Whistleblower Policy
Document Retention Policy

Special Practices & Reported Activities

Operated a School
Operated a Hospital
Provided First Class Travel
Reported Conflict of Interest
Reported Asset Diversion
Excess Benefit Transaction
Made Political Expenditures
Engaged in Lobbying
Operated Donor Advised Fund
Maintained Art Collections
Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
7
$149,468
Total Directors
13
$0
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
JOYCE A KULLMAN EXECUTIVE DI 40.00
Officer
$126,647 $22,821 $149,468
KEVIN BYRAM MD PRESIDENT 4.00
Officer Director
$0 $0 $0
SARA BAIRD AMODIO MSW EDD PAST PRESIDE 4.00
Officer Director
$0 $0 $0
ELIZABETH BRANDT MD SECRETARY 4.00
Officer Director
$0 $0 $0
DON NAGLE TREAS - ENDI 4.00
Officer Director
$0 $0 $0
WILLIAM ANDREWS TREAS - BEG 4.00
Officer Director
$0 $0 $0
BRIAN GOLDMAN VP OF RESOUR 4.00
Officer Director
$0 $0 $0
JOCELYN ASHFORD DIRECTOR 4.00
Director
$0 $0 $0
CAZ CAZANOV DIRECTOR 4.00
Director
$0 $0 $0
NOELLE CREAMER DIRECTOR 4.00
Director
$0 $0 $0
VIMAL DEREBAIL MD DIRECTOR 4.00
Director
$0 $0 $0
ANISHA B DUA MD MPH DIRECTOR 4.00
Director
$0 $0 $0
DAHLIA MAK DIRECTOR 4.00
Director
$0 $0 $0
SEBASTIAN SATTUI MD DIRECTOR 4.00
Director
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2025 $2,508,810 $2,383,106 $6,087,497 $125,704
2024 $2,956,706 $2,090,325 $5,594,826 $866,381
2023 $3,247,457 $1,290,245 $4,528,503 $1,957,212
2022 $1,569,283 $1,080,323 $2,457,931 $488,960
2021 $1,330,516 $895,702 $2,082,111 $434,814
2020 $1,156,554 $1,391,377 $1,661,666 $-234,823
2019 $1,413,621 $1,086,332 $1,855,438 $327,289
2018 $1,081,157 $985,876 $1,500,959 $95,281
Explore More Nonprofits
Top 100 Nonprofits in Missouri Largest U.S. Nonprofits Best Rated Nonprofits Most Efficient Nonprofits

Compare VASCULITIS FOUNDATION with other nonprofits in Missouri and across the country.